US · guidance

NCD 220.6.9

FDG PET for Refractory Seizures

activein force · 2005-01-28 – presentact-effective-date

Indications and Limitations of Coverage

Beginning July 1, 2001, Medicare covers FDG-PET for pre-surgical evaluation for the purpose of localization of a focus of refractory seizure activity.

Limitations: Covered only for pre-surgical evaluation.

Documentation that these conditions are met should be maintained by the referring physician in the beneficiary's medical record, as is normal business practice.

(This NCD last reviewed June 2001.)

Cross Reference

See NCD for PET Scans (§220.6).

Revision History

04/2005 - Removed text from PET Scans NCD (§220.6) and created a separate NCD. Effective date 01/28/05. Implementation date 04/18/05. (TN 31) (CR 3741)

History

Version 1

Provenance

Source: cms.gov
Retrieved: 2026-08-26
Edition: mcd-2026-08-26
Content hash: a207f0089d3c1823372a8247626a1a60e0e171d7d233e30cf7d56d953054eb25

View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs